U.S. Real Estate Stock News

Mercury Systems, Inc. recently announced it was awarded a contract by L3Harris Technologies to supply radiation-tolerant solid-state data recorders for the U.S. Space Development Agency’s Tranche 3 Tracking Layer satellite constellation, extending its role across all four tracking tranches in the Proliferated Warfighter Space Architecture. This latest award, which moves L3Harris to Mercury’s highest-capacity data recorder in a 3U VPX form factor, underscores Mercury’s entrenched position in...

Sector excitement puts Iridium’s spectrum and conference updates in focus Iridium Communications (IRDM) has been pulled into the spotlight after a sharp share price move linked to broader satellite sector excitement following the SpaceX IPO filing and Amazon’s reported interest in Globalstar. For investors, that sector wide enthusiasm is intersecting with company specific factors, including Iridium’s scarce L-Band and S-Band spectrum holdings and recent technology updates discussed at the...

Investors may be asking whether Ares Management, at around US$102 a share, is offering good value right now or whether the recent price reflects too much optimism in the stock. The share price has pulled back recently, with a 5.1% return over the last 7 days, 9.1% over 30 days, 38.4% year to date, and 18.9% over 1 year, while still showing 40.4% and 116.0% returns over 3 and 5 years respectively. Recent coverage has focused on how Ares Management fits within the broader capital markets...

In late March 2026, AbbVie detailed extensive new clinical and real-world dermatology data for Skyrizi and Rinvoq at the American Academy of Dermatology meeting, while also facing investor scrutiny over a shareholder proposal to require an independent board chair. At the same time, market concern about potential US tariffs on imported branded and patented drugs has raised fresh questions about AbbVie’s exposure to shifting drug-pricing and trade policies. Next, we’ll examine how heightened...

Sable Offshore has restarted oil sales from the Santa Ynez Unit and Pipeline System off southern California, following a Defense Production Act order and years of regulatory and operational delays, with key offshore platforms gradually returning to service since mid-March 2026. This restart not only revives one of California’s major offshore oil hubs but also puts Sable’s permitting, environmental risk management, and future dividend plans under closer investor and legal scrutiny. We’ll now...

In late March 2026, Vicor’s share price weakened after CEO Patrizio Vinciarelli sold 50,000 shares and other insiders executed smaller sales, amplifying trading volumes and volatility despite reports of strong financial performance and rising revenues. The insider selling has sharpened investor focus on leadership confidence and ownership structure, raising fresh questions about how closely management’s actions align with Vicor’s long-term power electronics growth story. We’ll now examine...

Dividend announcement and stock reaction National HealthCare (NHC) announced a cash dividend of $0.64 per share, with the ex-dividend date aligning with the announcement. This puts the payout policy and short-term price behavior in focus for income-oriented investors. See our latest analysis for National HealthCare. The dividend news comes after a 24.8% 90 day share price return and a 77.88% 1 year total shareholder return. This suggests recent momentum has been building from already strong...

Powell Industries has already implemented a three-for-one forward stock split, effective April 1, 2026, alongside an amendment to its Delaware certificate of incorporation that increased authorized common shares from 30 million to 90 million and set total authorized capital at 95 million shares including preferred stock. This move not only lowers the price per share and potentially broadens retail access, it also gives management greater flexibility for future equity needs such as...

Henry Schein (HSIC) is back on investors’ radar after recent share price moves, with the stock showing mixed returns over the past year and over longer periods, which may prompt a closer look at its fundamentals. See our latest analysis for Henry Schein. Recent trading has been choppy, with a 1-day share price return of 1.23% and a 30-day share price return of a 7.82% decline. However, the 1-year total shareholder return of 11.04% indicates that longer term holders have still seen gains,...

Quantum Computing Inc. (NasdaqCM:QUBT) has completed the acquisition of NuCrypt, a specialist in photonics and quantum communications. The deal brings NuCrypt’s systems together with QCi’s thin film lithium niobate photonic technology, with an aim to shrink device size, improve performance and support scalable manufacturing. Quantum Computing Inc., now trading at a share price of $6.87, has had a mixed return profile, including a very large 3 year gain alongside a 37.6% decline year to date...

Collegium Pharmaceutical: Recent Returns Put Valuation in Focus Collegium Pharmaceutical (COLL) has drawn investor attention after a recent pullback, with the share price down about 19% over the past month and roughly 29% over the past 3 months. See our latest analysis for Collegium Pharmaceutical. At a share price of $32.31, Collegium Pharmaceutical has seen momentum fade in recent weeks, with a 30 day share price return of 19.2% and a year to date share price return of 29%, even as the 1...

Recently, JetBlue announced past and upcoming changes including higher checked baggage fees tied to rising jet fuel costs, expanded service and added frequencies at Fort Lauderdale-Hollywood International Airport, and enhancements to its TrueBlue loyalty program such as subscriptions and broader points redemption options. At the same time, reports that JetBlue is exploring a potential sale while pressing ahead with its JetForward turnaround plan highlight how the airline is trying to balance...

Ultragenyx Pharmaceutical recently announced that the FDA accepted for review its resubmitted BLA for UX111, an AAV9 gene therapy for Sanfilippo syndrome Type A, setting a PDUFA action date of September 19, 2026 and acknowledging robust long-term neurodevelopmental and biomarker data with an acceptable safety profile. This progress, alongside FDA clearance of the IND for UX016 in GNE myopathy, highlights Ultragenyx’s deepening focus on late-stage gene and rare disease therapies backed by...

Hinge Health (NYSE:HNGE) is extending its musculoskeletal care platform to cover more than 5 million public sector employees across the US. The expansion includes 24 state employee health plan clients and a range of public institutions spanning state and local governments and higher education. This rollout broadens Hinge Health's reach to public sector populations in all 50 states. For investors watching NYSE:HNGE, this public sector expansion comes as the stock trades at $38.98, with...

U-Haul Holding (NYSE:UHAL) has opened its first company-owned retail, moving, and storage facility in Rossford, Ohio. The new site expands U-Haul's physical presence and services in Northwest Ohio, bringing additional storage capacity and rental options to local residents. The facility is expected to create local jobs and increase access to moving solutions for households and businesses in a previously unserved area. U-Haul Holding, trading at around $47.29 per share, is adding bricks and...

Lakeland Financial: recent performance catches investor attention Lakeland Financial (LKFN) is back on some investors’ radars after a mixed run in the share price, with a small gain over the past 3 months following a modest pullback over the past month. See our latest analysis for Lakeland Financial. At around $58.12 per share, Lakeland Financial’s recent 7 day share price return of 2.04% contrasts with a softer 30 day move, while the 1 year total shareholder return of 7.92% points to...

This article examines whether DexCom is fairly priced at current levels by focusing on what investors receive for the price they pay. DexCom's share price recently closed at US$62.22, reflecting returns of a 5.9% decline over 7 days, a 14.9% decline over 30 days, a 6.5% decline year to date, a 0.7% change over 1 year, a 44.7% decline over 3 years and a 34.2% decline over 5 years, which provides important context for any valuation view. Recent news coverage has centered on DexCom's role in...

In recent weeks, Coherent Corp. has expanded its AI datacenter footprint through a 400 Gbps silicon photonics breakthrough with Tower Semiconductor, unveiled at OFC, while also preparing technical presentations at ICDT 2026 in Chongqing and SEMICON China 2026 in Shanghai. At the same time, Coherent’s index inclusion and enlarged, multi‑billion‑dollar supply relationship with Nvidia are reshaping its role in next‑generation AI infrastructure and datacenter optics. Now we’ll explore how the...

In March 2026, Churchill Downs Incorporated announced that a U.S. District Court in Kentucky ruled the Horseracing Integrity and Safety Authority’s purse‑weighted fee methodology and related fee collection efforts unlawful, calling them arbitrary and capricious. By underscoring what its CEO describes as regulatory overreach and fiscal mismanagement at HISA, the ruling could reshape Churchill Downs’ compliance costs and its role in U.S. horseracing governance. Next, we’ll examine how this...

If you are wondering whether T-Mobile US at around US$201.40 is pricing in too much optimism or not enough, the current numbers offer a useful starting point for that question. The stock is roughly flat year to date with a 0.9% return. However, that sits alongside a 7.8% decline over 30 days, a 4.8% decline over 7 days, and a 23.5% decline over the past year, even after 3-year and 5-year returns of 40.0% and 61.0%. Recent headlines have focused on T-Mobile US as a major US wireless carrier,...

Why Urban Edge Properties is on investors’ radar today Urban Edge Properties (UE) continues to trade around recent levels, with shares closing at US$20.37. This keeps the US$2.64b retail REIT in focus for investors watching income oriented real estate names. See our latest analysis for Urban Edge Properties. Recent trading has been mixed, with a 2.41% 1 day share price return and a 6.65% year to date share price return set against a 2.81% 1 month pullback. At the same time, the 1 year total...

Bullish (BLSH) has drawn fresh attention after recent price moves, with a 3.7% gain over the past day and just under 10% over the past month, despite weaker performance across the past 3 months. See our latest analysis for Bullish. With the share price at $36.37, Bullish shows mixed momentum, with a 1 month share price return of 9.8% alongside a 90 day share price return decline of 7.4%, suggesting interest has picked up recently after earlier weakness. If you are looking beyond Bullish to...

In its recently reported 2025 results, ZTO Express (Cayman) highlighted strong parcel volume growth, market share gains, and technology-driven efficiency improvements, while authorizing a US$1.50 billion share repurchase program and pledging to return at least half of adjusted earnings to shareholders. An interesting takeaway is that ZTO is pairing its operational expansion with sizable shareholder returns, signaling confidence in cash generation despite rising costs and some margin...

Insider selling and policy shifts put CoreCivic (CXW) in focus CoreCivic (CXW) is drawing attention after Chief Administrative Officer Cole Carter sold 12,500 shares under a pre arranged plan, alongside news that ICE intends to scale back privately operated detention facilities. See our latest analysis for CoreCivic. CoreCivic’s recent 1 day share price return of 7.21% to US$20.51 follows a 30 day share price return of 11.83% and a 3 year total shareholder return of about 120%. This suggests...